The global Bone Cement & Glue Market is projected to reach USD 2,248 million by 2028 from USD 1,644 million in 2023, at a CAGR of 6.5% during the forecast period. The growth of this market is due to the Growing incidence of sports injuries and Rapid growth in geriatric population. However, Unfavourable reimbursement scenario may restrain the growth of this market.
The Bone Cement & Glue Market is competitive and is dominated by various players. Stryker (US), Zimmer Biomet (US), DePuy Synthes (a subsidiary of Johnson & Johnson - US), Smith+Nephew. (UK), Arthrex, Inc. (US), Enovis (US), Globus Medical (US), Exactech, Inc. (US), Heraeus Holding (Germany), Artivion, Inc (US), Cardinal Health. (US), Teknimed (France), Medtronic (Ireland), Tecres S.p.A. (Italy), Bioceramed, S.A. (Portugal), and Evolutis (France).
To know about the assumptions considered for the study download the pdf brochure
Stryker accounted for the largest share of the bone cement market in 2022. The company provides VertaPlex and Simplex range of bone cements. Stryker adopted acquisition and other development such as launching new R&D in India as its key strategies to maintain its leading position in the bone cement market. Stryker is a prominent player in the Bone cement & glue products market due to its strong brand recognition and comprehensive suite of products such as VertaPlex, and SpinePlex. Stryker offers an exhaustive portfolio of medical devices, equipment, and technologies across various segments, including Orthopedics, neurotechnology, medical and surgical, and spine. Its diverse product range allows the company to cater to a wide range of medical needs and serve multiple specialties within healthcare.
Zimmer Biomet (US)
Zimmer Biomet held the second-largest share of the bone cement market in 2022. The company provides Antibiotic/Non-antibiotic loaded bone cement such as Conflow Bone Cements, Refobacin Bone Cement R and Biomet Bone Cement R. The company has a strong geographical presence around the world which also helps it to maintain its leading position in the bone cement market. Zimmer Biomet mainly focuses on acquisitions strategies to enhance its product portfolio and geographical reach around the world. For instance, in March 2022, it completed the spinoff of spine and dental businesses into a new public company, ZimVie Inc. (US) (“ZimVie”). The transaction was intended to benefit its stockholders by enhancing the focus of both Zimmer Biomet and ZimVie to meet the needs of patients and customers.
Heraeus Medical accounted for the third largest share of the bone cement market in 2022. The company has a wide product portfolio of bone cements. Heraeus Medical offers bone cement for Orthopedic Applications such as vertebroplasty or kyphoplasty and spine surgeries. The leading position of the company is majorly attributed to the wide adoption of its PALACOS and OSTEOPAL bone cement. For instance, the most used bone cement in Australia and the United Kingdom is PALACOS R which has been used in over 30 million procedures. In a recent award-winning study by the Hospital for Special Surgery, PALACOS R was associated with 3x fewer revisions for early aseptic loosening than Cobalt HV and Simplex HV bone cements (Source: Heraeus Holding 2023).
Bone Cement & Glue Market by Bone Cement (PMMA, Calcium Phosphate), Bone Glue (Natural, Synthetic), Loading (Antibiotic Loaded), Application (Arthroplasty, Kyphoplasty, Vertebroplasty), End User (Hospitals, ASCS, Clinics) - Global Forecast to 2028
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE